about
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia ADiagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disordersvon Willebrand's disease: a report from a meeting in the Åland islandsVon Willebrand disease-associated angiodysplasia: a few answers, still many questions.Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyCost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context.Treatment of patients with von Willebrand disease.Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).Similarity in joint function limitation in Type 3 von Willebrand's disease and moderate haemophilia APrinciples of care for the diagnosis and treatment of von Willebrand disease.Management of inherited von Willebrand disease in 2007.Prophylaxis of bleeding episodes in patients with von Willebrand's disease.Evidence-based recommendations on the treatment of von Willebrand disease in Italy.Current management of patients with severe von Willebrand disease type 3: a 2012 update.von Willebrand disease and platelet disorders.Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study.Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.Current and Emerging Options for the Management of Inherited von Willebrand Disease.Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.The 80th anniversary of von Willebrand's disease: history, management and research.Current challenges in the diagnosis and management of patients with inherited von Willebrand 's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis.Von Willebrand disease in the elderly: clinical perspectives
P2860
Q26738507-48A4C1C0-07DB-42AC-B4CA-EEBD66DD4397Q33608224-102BFDA7-CAE0-4CA1-AF76-BDACEFD1D751Q34223268-70BF26A2-2726-4197-9419-E1597B1DB8D4Q34329176-F38B0C75-1C8A-48E3-9C74-6A4CB0A5EB7CQ34416394-22AC9840-5B37-42AE-82C9-C382CAA1AB4BQ34758065-EF013C31-999F-412F-ADF1-8014AE880EB9Q35683876-6A65C058-4A8E-449E-B142-7B3EC5F322BAQ35887945-BCB7671B-3361-4110-9175-B9C98789C563Q35985208-82F28A8C-A620-4F71-83F1-B78C090112B6Q36805813-A0C3A93E-16DC-4B1D-8521-86E25B453D6CQ36911419-E754B692-687B-4C3B-837E-7546E2A223C5Q37119655-A993E855-A628-4A74-9357-426C5AC537A4Q37209112-4023A04A-4997-46AB-ABDC-ED20985DC53AQ38020749-2E9EBCA1-30B8-44E0-B0F4-EF27F2952075Q38206854-A57DA4C3-A617-4D99-A968-38FC785521E8Q38452336-D870A4E3-A0B9-49D0-8D88-D77BDA5B128DQ39835946-1838ADED-DD8F-40CD-B252-D3D0D43A1822Q41100189-F585E999-388D-44D5-8457-127BC6658288Q41620644-3AE2F91C-A8B5-4D30-BAD4-E6FA7FE0CF5AQ44320698-C1AEE6B7-3016-4A78-95A9-0EFFC9F6CC3FQ45863536-75954739-6B32-4859-ABB7-477A145C3EFCQ48545948-86BB7029-7ACE-49DA-9045-062954C5230CQ58781583-B84AEA0D-C895-4C73-9DD9-4F1690BB1BDC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Long-term prophylaxis in von Willebrand disease.
@ast
Long-term prophylaxis in von Willebrand disease.
@en
type
label
Long-term prophylaxis in von Willebrand disease.
@ast
Long-term prophylaxis in von Willebrand disease.
@en
prefLabel
Long-term prophylaxis in von Willebrand disease.
@ast
Long-term prophylaxis in von Willebrand disease.
@en
P1476
Long-term prophylaxis in von Willebrand disease.
@en
P2093
Erik Berntorp
Pia Petrini
P356
10.1097/01.MBC.0000167659.23262.18
P478
16 Suppl 1
P577
2005-04-01T00:00:00Z